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A 59-year-old man presented with severe paroxysms of cough associated with dyspnea. His CT scan
showed diffuse bilateral ground glass opaciﬁcations. His bronchoalveolar lavage ﬂuid was consistent with
pulmonary alveolar proteinosis. Transbronchial biopsy, microbiological studies, and cytology did not
identify any alternative diagnosis. The patient had a history of working as a textile loom technician for
thirty-one years and had signiﬁcant exposure to cotton dust. He responded well to whole lung lavage
with improvement of symptoms, gas exchange, and CT scan. This patient represents the third reported
case of pulmonary alveolar proteinosis associated with cotton dust exposure. We suggest that cellulose
might be useful in animal models of pulmonary alveolar proteinosis.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Pulmonary alveolar proteinosis (PAP) is a rare lung disease
resulting from the accumulation of surfactant in the alveolar
spaces.1e3 These patients present with dyspnea, cough, chest pain,
fatigue, and exercise limitation; 30% of patients are asymptomatic
and have a delayed diagnosis.4,5 The current classiﬁcation of PAP
includes congenital, primary (idiopathic), and secondary disorders.4
Primary PAP was recently discovered to be an autoimmune disease
with autoantibodies against granulocyte-macrophage colony stim-
ulating factor (GM-CSF).6e9 Reduced levels of GM-CSF disrupt alve-
olarmacrophagematuration and reduce themacrophage’s ability to
effectively catabolize surfactant. Secondary PAP occurs in conditions
in which alveolar macrophage function is abnormal; these include
hematologic malignancies, immunodeﬁciencies, chronic inﬂam-
matory states, and exogenous exposures to different particles.6,10
Two cases of PAP associated with cotton dust exposure have been
reported in the literature.11,1 We now report a third case and discuss
the possible role of cellulose in the pathogenesis.2. Case report
A 59-year-old man with no signiﬁcant past medical history
presented to our facility with a three-week history of weakness and
cough. He had cough paroxysms which lasted from two to 20 min.
He had minimal sputum production and did not have signiﬁcant
dyspnea between episodes of cough. He worked as a textile loom: þ1 806 743 3148.
gent).
rved.technician for 31 years and had signiﬁcant exposure to cotton dust.
He wore a respiratory mask at work only during the last ﬁve years
of work. His work involved cleaning and repairing equipment with
water and/or air hoses. Cotton dust was aerosolized, and he was
covered with dust at the end of the day. He quit smoking over
twenty years ago.
Physical examination revealed mild respiratory distress with
cough paroxysms. Chest examination revealed a few scattered
crackles. Initial CBC included a white blood count of 11.1 kU/L,
a hemoglobin of 14.1 gm/dl, and a platelet count of 43,000 kU/L. His
LD was elevated (670 U/L). Initial arterial blood gases revealed
a pH of 7.4, a PaCO2 of 34 mmHg, a PaO2 of 168 mmHg on a non-
rebreather mask with an approximate FiO2 of 50%. Chest x-ray
revealed normal lung volumes and diffuse nodules. CT scan
revealed bilateral diffuse ground glass opaciﬁcations (Fig. 1).
The patient then underwent bronchoscopy which revealed
some blood in the airways; the BAL ﬂuid was milky in appearance
with a red blood count of 22,000/cm and a white blood count of
100/cm (79% neutrophils). Bacterial, viral, fungal, and mycobacte-
rium cultures were negative. A transbronchial biopsy revealed
proteinaceous material in the alveolar spaces. There was no evi-
dence of malignancy. The patient underwent two whole lung
lavages with recovery of large amounts of milky proteinaceous
material. He respondedwell, and subsequent ABGs and chest x-rays
improved. His most recent high resolution CT was clear.3. Discussion
Recent studies on the pathogenesis of primary PAP have identi-
ﬁed antibodies against GM-CSF in these patients. This cytokine
stimulates the terminal differentiation of macrophages which is
Fig. 1. This high resolution CT reveals diffuse ground glass opaciﬁcations.
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Hence, low levels of GM-CSF limit the catabolism of surfactant and
allow its accumulation in alveolar spaces. Patients with secondary
PAP often have abnormalities in macrophage production, macro-
phage differentiation, and/or macrophage function but do not have
these antibodies.MostpatientswithPAPhavebeen chronic cigarette
smokers, and reactant oxidants in cigarette smoke could contribute
to the macrophage dysfunction and further impair catabolism.
Pulmonary alveolar proteinosis secondary to chronic exogenous
exposures occurs infrequently and has not been well characterized.
Relevant exposures include aluminum dust, silica, fertilizer dust,
gasoline fumes, agriculturaldust, cleaningproducts, nitrogendioxide,
paint, and cotton dust.13 The majority of these patients do not have
anti-GM-CSF antibodies. There have been only two cases in the
literature that reported cotton dust exposure as a cause of PAP. The
ﬁrst case occurred in a 26-year-old manwho worked as a spinner in
India for eight years without proper respiratory protection; he
eventually died from PAP complications.12 The second case occurred
in Poland in a 55-year-old woman with a 20-year history of cotton
dust exposure.11 She improved signiﬁcantly after lung lavage.
Our patient had sustained high level exposure to cotton dust and
was an ex-smoker at the time of presentation. His smoking could
have increased particulate retention in the lung if he had subclinical
airway disease which caused mucociliary dysfunction.3 The mech-
anism(s) by which dust and particles cause lung injury depends on
the particulate and the exposure level. Cotton dust ﬁbers are 90%
cellulose, an organic polysaccharide made up of hundreds to thou-
sands of glucosemolecules linkedwith beta-acetal linkages. Humancells lack the enzyme to break apart the beta links and cannot digest
this compound.14,15 Hence ingested cellulose may persist in mac-
rophages and cause phagocyte overload. This would limit the
phagocytosis of surfactant and exogenous pathogens. In addition,
ingested cellulose could trigger an inﬂammatory process which
releases cytokines, reactive oxidants, and proteolytic enzymes.
Animal studies have demonstrated that inhaled cellulose triggers
a neutrophil and lymphocyte inﬂux into the rat lung. Lung macro-
phages from these animals incubated in vitro after exposure release
tumor necrosis factor alpha, especially when co-incubated with
endotoxin. However, this cellular inﬂux and tumor necrosis factor
alpha release both decline over time evenwith continued inhalation
of cotton dust.14 This initial inﬂammatory process could cause
alveolar pneumocyte type II dysfunctionwith either overproduction
of surfactant or decreased recycling. In addition, acute inﬂammation
could alter macrophage function and reduce surfactant clearance.
Studies with this rat model support the following speculation.
Cotton dust inhalation stimulates an acute inﬂammatory response
which subsides over time possibly secondary to macrophage over-
load. However, the persistent dust exposure maintains the macro-
phage overload which reduces the surfactant clearance. This
sequence would result in diffuse alveolar ﬁlling with minimal
change in lung architecture.6e8,13 Other factors may also contribute
to the pathogenesis of alveolar ﬁlling. Aqueous extracts of cotton
dust alter the biophysical properties of surfactant, and these phys-
ical changes might alter Type 2 cell recycling or macrophage clear-
ance.16 Cotton dust also contains cotton bract and endotoxin which
have direct effects on the airway. These toxins potentially reach the
A. Moreland et al. / Respiratory Medicine CME 4 (2011) 121e123 123alveolar spaces and could alter either Type 2 cell or macrophage
function.17 Finally, rare patients with exogenous exposures, espe-
cially silica, have autoimmune responses which could produce anti-
GM-CSF antibodies.
Bronchoalveolar lavage and transbronchial biopsy are usually
done in these patients to obtain ﬂuid and tissue for microbiological
andpathological studies. Thepresence of lipoproteinaceousmaterial
in the bronchial lavage ﬂuid without evidence of infection or mal-
ignancy is a typical diagnostic ﬁnding. A serum assay for anti-GM-
CSF antibodies is available in some centers, but the clinical utility of
this test is still uncertain.4,6,13 These patients have abnormal
neutrophils and macrophages and are susceptible to a wide variety
of opportunistic pathogens.4,6e9 The standard treatment for symp-
tomatic PAP remains whole lung lavage which washes surfactant
from the alveolar spaces and improves gas exchange.12,13,18,19 Mouse
models have demonstrated that exogenous GM-CSF improves
alveolar proteinosis. Three published clinical trials have shown
beneﬁt with injectable GM-CSF in patients with PAP, but this
approach has deﬁnite limitations (cost and frequent relapse).6,12,18
Continued research is needed in this area, and the development of
aerosol therapies for more targeted delivery of treatment may
provide better results.
In summary, this report describes the third patient with cotton
dust exposure and alveolar proteinosis. It emphasizes the impor-
tance of the exposure history in patients presenting with diffuse
lung diseases and suggests that animal models using cellulose
might provide a good model for PAP and alveolar macrophage
overload syndromes.
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